The iBGStar Blood Glucose Monitoring System by AgaMatrix received U.S. Food and Drug Administration (FDA) approval on December 7, 2011. It became available for purchase on May 2, 2012.
Meters & Monitors
One big problem with blood glucose meters has long been that you can’t convert the individual readings into patterns and trends so you can figure out what to do about them. Oh, sure, many meters have software that does this in one fashion or another but downloading the data into software is often difficult because the cable you need is unavailable or lost or left at home or the office. Even a bigger problem occurs when you take the meter to the doctor’s office and they don’t have a cable to use to download data to software for the doctor to analyze and make recommendations.
Dexcom is making more friends. Already having partnerships with Animas and Omnipod, Dexcom has now signed a research and development agreement with Roche Diagnostics U.S. The plan is to integrate Dexcom's continuous glucose monitor into Roche's insulin pumps so you can see trends and blood glucose data in one handheld device.
Here's an excerpt from the announcement:
Successful diabetes management starts with accurate numbers. WaveSense is a new technology that personalizes each test to provide world class accuracy. It detects and corrects for common sources of error that make blood glucose measurements inaccurate. Some of the common errors are:
Blood Samples - Blood sample variations such as hematocrit level (the amount of red blood cells in the sample) or chemical interferences from food or beverages (such as vitamin C from orange juice).
The Swiss medical device company, Solianis, is developing products for physiological glucose monitoring, including a non-invasive, continuous glucose monitoring device. Based on impedance spectroscopy, their device uses radio waves and changes in skin resistance to monitor changes in blood composition. Solianis employs a multi-sensor approach to monitor various factors, including body temperature, microcirculation, sweat, moisture in the skin and the thickness of different skin layers as often as once a minute.
GlySens Incorporated is a privately held corporation located in San Diego, California that's been around since 1998. Their focus is on an implantable long term continuous glucose monitoring sensor that will help people with diabetes monitor their glucose levels accurately without the usual fingersticks. The system will include 2 parts: the implanted sensor and an external monitor with a display.